1. Hepatocellular carcinoma: Exploring the impact of ethnicity on molecular biology
   Angela Lamarca et al, 2016, Critical Reviews in Oncology/Hematology CrossRef
2. Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
   Zhao-Shan Niu et al, 2022, World Journal of Gastroenterology CrossRef
3. Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features
   Dragana Kopanja et al, 2015, Journal of Hepatology CrossRef
4. Targeting the effect of sofosbuvir on selective oncogenes expression level of hepatocellular carcinoma Ras/Raf/MEK/ERK pathway in Huh7 cell line
   Muhammad Atif et al, 2022, Saudi Journal of Biological Sciences CrossRef
5. Knockdown of mutated H-Ras V12 expression induces chemosensitivity of hepatocellular carcinoma cells to cisplatin treatment in vitro and in nude mouse xenografts
   FANJIE MENG et al, 2014, Oncology Reports CrossRef
6. Molecular remission using personalized low-dose immunotherapy with minimal toxicities for poor prognosis hematological and solid tumor cancers
   Dipnarine Maharaj et al, 2023, NK Cells in Cancer Immunotherapy: Successes and Challenges CrossRef
7. Proteomic analysis revealed common, unique and systemic signatures in gender-dependent hepatocarcinogenesis
   Huiling Li et al, 2020, Biology of Sex Differences CrossRef
8. H-ras-targeted genetic therapy remarkably surpassed docetaxel treatment in inhibiting chemically induced hepatic tumors in rats
   Alankar Mukherjee et al, 2024, Life Sciences CrossRef
9. Etiology and Pathogenesis of Hepatocellular Carcinoma: Transcription Factors, Signal Pathways Regulating Proliferation and Apoptosis, and Telomeres/Telomerases
   Arthur Zimmermann, 2016, Tumors and Tumor-Like Lesions of the Hepatobiliary Tract CrossRef
10. Etiology and Pathogenesis of Hepatocellular Carcinoma: Transcription Factors, Signal Pathways Regulating Proliferation and Apoptosis, and Telomeres/Telomerases
    Arthur Zimmermann, 2017, Tumors and Tumor-Like Lesions of the Hepatobiliary Tract CrossRef
11. Hepatocellular carcinoma: Where are we in 2018?
    William C. Chapman et al, 2018, Current Problems in Surgery CrossRef
12. Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis
    Bing Han et al, 2016, Oncotarget CrossRef
13. p19Arf inhibits aggressive progression of H-ras-driven hepatocellular carcinoma
    Dragana Kopanja et al, 2018, Carcinogenesis CrossRef